NSE filing, NSE: IEML. Summary written from the filing by ALFA Finder's alert engine.
Indian Emulsifiers Ltd: key numbers
- Share price
- ₹36.00
- Market cap
- ₹132.0 Cr
- Revenue (annual)
- ₹159.8 Cr
- Net profit (annual)
- ₹19.34 Cr
- P/E (TTM)
- 6.8×Sector 35.1×
- Promoter holding
- 32.64%
- FII holding
- 2.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Emulsifiers Ltd
All →Indian Emulsifiers Results Update
Indian Emulsifiers released an H1 FY27 press release showing strong revenue and profit growth year-on-year. Margins recovered, though finance costs rose as the company expanded capacity.
Indian Emulsifiers H1 FY27 Results: Net Profit ₹15.5 Cr, Up 50.5% YoY
Indian Emulsifiers Ltd reported revenue from operations of ₹133.8 Cr (+73.8% YoY) and net profit of ₹15.5 Cr (+50.5% YoY) for H1 FY27.
- Key figure
- Net profit ₹15.5 Cr · +50.5% YoY
Indian Emulsifiers Other Announcement
Indian Emulsifiers shifted its registered office within Mumbai, effective November 2, 2026. The move is a local address change with no financial impact disclosed.
Indian Emulsifiers Fund Raise of ₹49.5 Cr
Indian Emulsifiers Limited approved a rights issue of equity shares at ₹27 per share. The company plans to raise approximately ₹49.50 Crore.
- Value
- ₹49.50 Cr
Indian Emulsifiers Capital Structure Change
Indian Emulsifiers is conducting a rights issue of 1,83,33,222 equity shares at ₹27 per share, aggregating ₹49.50 Crore. The record date is October 27, 2026.
- Value
- ₹49.50 Cr
Indian Emulsifiers Other Announcement
Indian Emulsifiers Limited informed NSE that the Reg 27 Corporate Governance Report is non-applicable for Q2 FY 2026-27 due to its SME listing.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr